Atorvastatina tecnigen 40 mg comprimidos recubiertos con pelicula efg

Package Leaflet: Information for the User

Atorvastatina TecniGen 40mg Film-Coated Tablets

Read this leaflet carefully before you start taking this medicine because it contains important information for you.

- Keep this leaflet, as you may need to read it again.

• If you have any questions, ask your doctor or pharmacist or nurse.
• This medicine has been prescribed for you. Do not pass it on to others even if their symptoms are the same. It may harm them.
• If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, pharmacist or nurse. See section 4.

1. What Atorvastatina TecniGen is and what it is used for

2. What you need to know before you take Atorvastatina TecniGen

3. How to take Atorvastatina TecniGen

4. Possible side effects

5. Storage of Atorvastatina TecniGen

6. Contents of the pack and additional information

Atorvastatina TecniGen belongs to a group of medications known as statins, which are medications that regulate lipids (fats).

Atorvastatina TecniGen is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have failed. If you have a high risk of heart disease, Atorvastatina TecniGen may also be used to reduce this risk even if your cholesterol levels are normal. During treatment, a standard low-cholesterol diet must be followed.

Do not take Atorvastatina TecniGen if:

• You are allergic (hypersensitive) to atorvastatin or to any other medication used to reduce blood lipids or to any of the other components of this medication – see more details in Section 6.
• You have or have had any liver disease.
• You have or have had unjustified abnormal results in liver function blood tests.
• You are a fertile woman and do not use adequate contraceptive measures.
• You are pregnant or trying to become pregnant.
• You are breastfeeding.
• You are using the combination of glecaprevir/pibrentasvir for the treatment of hepatitis C.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Atorvastatina TecniGen.

• If you are taking or have taken in the last 7 days a medication that contains acid (used for the treatment of bacterial infection) by oral or intravenous route, the combination of acid fusidic and Atorvastatina TecniGen may produce severe muscle problems (rhabdomyolysis).
• If you have or have had myasthenia (a disease that courses with generalized muscle weakness that, in some cases, affects the muscles used for breathing) or myasthenia ocular (a disease that causes weakness of the ocular muscles), as statins sometimes can worsen the disease or cause myasthenia (see section 4).

For the following reasons, Atorvastatina TecniGen may not be suitable for you if:

• You have had a previous stroke with cerebral bleeding, or have small embolisms of liquid in the brain due to previous strokes.
• You have kidney problems.
• You have a thyroid gland with low activity (hypothyroidism).
• You have repeated or unjustified muscle pain, personal or family history of muscle problems.
• You have had previous muscle problems during treatment with other medications for reducing lipids (for example, with another statin or fibrates).
• You regularly drink large amounts of alcohol.
• You have a history of liver problems.
• You are over 70 years old.

Consult your doctor or pharmacist before taking Atorvastatina TecniGen if you:

• Have severe respiratory insufficiency.

While you are taking this medication, your doctor will monitor if you have diabetes or risk of developing diabetes. This risk of diabetes increases if you have high levels of sugars and fats in the blood, overweight, and high blood pressure.

In any of these cases, your doctor may instruct you to have blood tests before and, possibly, during treatment with Atorvastatina TecniGen to predict the risk of suffering adverse effects related to muscle. It is known that the risk of suffering adverse effects related to muscle (for example, rhabdomyolysis) increases when taking certain medications at the same time (see section 2 “Use of other medications”).

Inform your doctor or pharmacist if you experience constant muscle weakness. Further tests and additional medications may be necessary to diagnose and treat this problem.

Use of Atorvastatina TecniGen with other medications

Inform your doctor or pharmacist if you are taking, have taken recently, or may have to take any other medication.

There are some medications that may affect the proper functioning of Atorvastatina TecniGen or the effects of these medications may be modified by Atorvastatina TecniGen. This type of interaction may reduce the effect of one or both medications. Alternatively, this combined use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in Section 4:

• Daptomycin (a medication used to treat skin and skin structure infections and bacteria present in the blood).
• Medications used to modify the functioning of your immune system, for example, cyclosporine.
• Certain antibiotics or antifungal medications, for example, erythromycin, clarithromycin, telithromycin, ketoconazole, itraconazole, voriconazole, fluconazole, posaconazole, rifampicin, acid fusidic.
• If you have to take acid fusidic orally to treat a bacterial infection, you will have to stop using this medication. Your doctor will instruct you when you can restart treatment with Atorvastatina TecniGen. The use of Atorvastatina with acid fusidic may produce muscle weakness, sensitivity, or pain (rhabdomyolysis). For more information on rhabdomyolysis, see section 4.
• Other medications for regulating lipid levels, for example, gemfibrozil, other fibrates, cholestyramine.
• Some calcium channel blockers used in the treatment of angina or high blood pressure, for example, amlodipine, diltiazem; medications for regulating your heart rhythm, for example, digoxin, verapamil, amiodarone.
• Medications used in the treatment of AIDS, for example, ritonavir, lopinavir, atazanavir, indinavir, darunavir, etc.
• Other medications that are known to interact with Atorvastatina TecniGen, including ezetimibe (which reduces cholesterol), warfarin (which reduces blood coagulation), oral contraceptives, and stiripentol (anticonvulsant for treating epilepsy), cimetidine (used for heartburn and peptic ulcers), phenazone (an analgesic), and antacids (products for indigestion containing aluminum or magnesium).

• Over-the-counter medications: St. John's Wort.
• Some medications used for the treatment of hepatitis C, such as telaprevir, boceprevir, and the combination of elbasvir/grazoprevir.

Taking Atorvastatina TecniGen with food, drinks, and alcohol

See section 3 for instructions on how to take Atorvastatina TecniGen. Please note the following:

Orange juice

Do not take more than one or two small glasses of orange juice per day, as large amounts of orange juice may alter the effects of Atorvastatina TecniGen.

Alcohol

Avoid drinking large amounts of alcohol while taking this medication. See details in section 2 “Be especially careful with Atorvastatina TecniGen”.

Pregnancy, lactation, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.

Do not take Atorvastatina TecniGen if you are fertile unless you take adequate contraceptive measures.

The safety of Atorvastatina TecniGen during pregnancy and lactation has not been demonstrated.

Driving and operating machinery

Do not drive if this medication affects your ability to drive. Do not handle tools or machinery if this medication affects your ability to handle them.

Atorvastatina TecniGen contains lactose.

If your doctor has indicated that you have an intolerance to certain sugars, consult with him before taking this medication.

Follow exactly the administration instructions for this medication as indicated by your doctor. If you have any doubts, consult your doctor or pharmacist again.

Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with Atorvastatina TecniGen.

The usual initial dose of Atorvastatina TecniGen is 10 mg once a day for adults and children aged 10 years and older. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of Atorvastatina TecniGen is 80 mg once a day for adults and 20 mg once a day for children.

Atorvastatina TecniGen tablets should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.

Your doctor will decide the duration of treatment with Atorvastatina TecniGen.

Ask your doctor if you think the effect of Atorvastatina TecniGen is too strong or too weak.

If you take more Atorvastatina TecniGen than you should

If you accidentally take too many Atorvastatina TecniGen tablets (more than your usual daily dose), consult your doctor or the nearest hospital or call the Toxicological Information Service, phone 91 562 04 20.

If you forget to take Atorvastatina TecniGen

If you forget to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for the missed doses.

If you interrupt treatment with Atorvastatina TecniGen

If you have any other doubts about the use of this medication or want to interrupt treatment, ask your doctor or pharmacist.

Like all medicines, Atorvastatina TecniGen may cause side effects, although not everyone will experience them.

If you notice any of the following serious side effects, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency service.

Rare: may affect up to 1 in 1000 patients:

• Severe allergic reaction that causes swelling of the face, tongue, and throat, which may make it difficult to breathe.

• Severe disease with severe peeling and inflammation of the skin; blisters on the skin, mouth, genitals, and eyes, and fever. Skin rash with pink-red spots, especially on the palms of the hands or soles of the feet that may form blisters.

• Muscle weakness, pain on palpation, pain or rupture or change in color of the urine to brown-red, and especially if you have discomfort or high fever, it may be due to an abnormal muscle rupture that can be fatal and cause kidney problems.

Very rare: may affect up to 1 in 10,000 patients:

• If you experience unexpected or unusual bleeding or bruising, this may suggest a liver problem. You should consult your doctor as soon as possible.
• Lupus-like syndrome (including rash, joint disorders, and effects on blood cells).

Other possible side effects with Atorvastatina TecniGen:

Frequent side effects(may affect up to 1 in 10 people) include:

• inflammationof the nasal passages, sore throat, nasal bleeding
• allergic reactions
• increases in blood sugar levels (if you are diabetic, monitor your blood sugar levels), increasedcreatine kinasein blood
• headache
• nausea, constipation, gas, indigestion, diarrhea
• joint pain, muscle pain, and back pain
• blood test results that may show abnormal liver function

Infrequent side effects(may affect up to 1 in 100 patients) include:

• anorexia (loss of appetite), weight gain, decreased blood sugar levels (if you are diabetic, continue to monitor your blood sugar levels carefully)
• nightmares, insomnia
• dizziness, numbness or tingling in the fingers of the hands and feet, reduced sensitivity to pain or touch, changes in taste, memory loss
• blurred vision
• ringing in the ears and/or head
• vomiting, belching, upper and lower abdominal pain, pancreatitis (inflammation of the pancreas that causes stomach pain)
• hepatitis (inflammation of the liver)
• rash, skin rash, and itching, hives, hair loss
• neck pain, muscle fatigue
• fatigue, feeling unwell, weakness, chest pain, inflammation, especially in the ankles (edema), increased temperature
• positive urine tests for white blood cells

Rare side effects(may affect up to 1 in 1000 patients) include:

• vision changes
• unexpected or unusual bleeding or bruising
• cholestasis (yellowing of the skin and eyes)
• tendon injury
• skin rash or ulcers in the mouth (drug reaction)
• skin lesions of purple color (signs of inflammation of blood vessels, vasculitis)

Very rare side effects(may affect up to 1 in 10,000 patients) include:

• allergic reaction - symptoms may include sudden hissing while breathing and chest pain or tightness, swelling of the eyelids, face, lips, mouth, tongue, or throat, difficulty breathing, collapse
• hearing loss
• gynecomastia (enlargement of breasts in men and women).

Unknown frequency (cannot be estimated from available data): Constant muscle weakness.

Myasthenia gravis (a disease that causes generalized muscle weakness that, in some cases, affects the muscles used for breathing).

Myasthenia ocular (a disease that causes weakness of the eye muscles).

Consult your doctor if you experience weakness in the arms or legs that worsens after periods of activity, double vision or eyelid drooping, difficulty swallowing or difficulty breathing.

Possible side effects of some statins (medicines of the same type):

• Sleep disorders, including insomnia and nightmares
• Memory loss
• Sexual dysfunction
• Depression
• Respiratory problems, including persistent cough and/or difficulty breathing or fever
• Diabetes. It is more likely if you have high blood sugar and fat levels, obesity, and high blood pressure. Your doctor will monitor you while taking this medication.

Reporting side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

Keep this medication out of the sight and reach of children.

Do not store at a temperature above 25°C.

Store in the original packaging.

Do not use this medication after the expiration date (CAD) that appears on the blister and on the packaging. The expiration date is the last day of the month indicated.

Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications that you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications that you no longer need. By doing so, you will help protect the environment.

Composition of Atorvastatina TecniGen 40 mg

- The active ingredient is atorvastatina.

Cada comprimido recubierto con película contains 40 mg of atorvastatina (as atorvastatina de calcio trihidrato).

The other components (excipients) are:

Core:

lactosa monohydrate,

microcrystalline cellulose,

polysorbate 80,

hydroxypropyl cellulose,

sodium croscarmellose,

butilhydroxyanisole (E 320),

trisodium phosphate,

magnesium stearate.

Coating:

Hypromellose,

triacetin,

di oxide of titanium (E 171).

Appearance of the product and content of the container

The film-coated tablets of Atorvastatina TecniGen 40 mg arefilm-coated, white, round, biconvex.

Atorvastatina TecniGen 40 mg is presented in boxes with blisters that contain 28 film-coated tablets.

Holder of the marketing authorization and responsible for manufacturing

Holder of the marketing authorization

Tecnimede España Industria Farmacéutica, S.A.

Avda. de Bruselas, 13, 3º D. Edificio América. Polígono Arroyo de la Vega,

28108 Alcobendas (Madrid). SPAIN

Responsible for manufacturing

ATLANTIC PHARMA - PRODUÇOES FARMACEUTICAS, S.A.

Rua da Tapada Grande, No 2 (Abrunheira, Sintra) - 2710-089 – Portugal

Or

MEDINFAR MANUFACTURING, S.A.

Parque Industrial Armando Martins Tavares

Rua Outeiro Da Armada, nº 5.

Condeixa-a-Nova, 3150-194. Portugal

Last review date of this prospectus: August 2024

The detailed and updated information of this medication is available on the webpage of the Spanish Agency of Medicaments and Health Products (AEMPS)http://www.aemps.gob.es/